PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-9.93%
Revenue decline while AVGO shows 0.59% growth. Joel Greenblatt would examine competitive position erosion.
2.50%
Cost growth above 1.5x AVGO's 0.75%. Michael Burry would check for structural cost disadvantages.
-29.32%
Gross profit decline while AVGO shows 0.51% growth. Joel Greenblatt would examine competitive position.
-21.54%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-55.74%
R&D reduction while AVGO shows 19.53% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.72%
Operating expenses reduction while AVGO shows 12.43% growth. Joel Greenblatt would examine advantage.
-15.94%
Total costs reduction while AVGO shows 6.00% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
12.31%
D&A growth less than half of AVGO's 4313.59%. David Dodd would verify if efficiency is sustainable.
70.19%
EBITDA growth 1.25-1.5x AVGO's 62.84%. Bruce Berkowitz would examine sustainability.
66.90%
Similar EBITDA margin growth to AVGO's 61.89%. Walter Schloss would investigate industry trends.
89.00%
Operating income growth while AVGO declines. John Neff would investigate advantages.
87.79%
Operating margin growth while AVGO declines. John Neff would investigate advantages.
-11.36%
Other expenses reduction while AVGO shows 3.38% growth. Joel Greenblatt would examine advantage.
110.90%
Pre-tax income growth while AVGO declines. John Neff would investigate advantages.
112.10%
Pre-tax margin growth while AVGO declines. John Neff would investigate advantages.
-94.39%
Tax expense reduction while AVGO shows 1023.08% growth. Joel Greenblatt would examine advantage.
103.86%
Net income growth while AVGO declines. John Neff would investigate advantages.
104.28%
Net margin growth while AVGO declines. John Neff would investigate advantages.
105.56%
EPS growth while AVGO declines. John Neff would investigate advantages.
105.56%
Diluted EPS growth while AVGO declines. John Neff would investigate advantages.
0.07%
Share count reduction exceeding 1.5x AVGO's 0.26%. David Dodd would verify capital allocation.
0.33%
Diluted share increase while AVGO reduces shares. John Neff would investigate differences.